Quality of life declines after first ischemic stroke. The Northern Manhattan Study.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 2918891)

Published in Neurology on June 23, 2010

Authors

M S Dhamoon1, Y P Moon, M C Paik, B Boden-Albala, T Rundek, R L Sacco, M S V Elkind

Author Affiliations

1: Neurological Institute, Department of Neurology, College of Physicians and Surgeons, Columbia University, 710 W. 168th Street, New York, NY 10032, USA. msd2102@mail.cumc.columbia.edu

Articles citing this

Effect of insurance status on postacute care among working age stroke survivors. Neurology (2012) 1.11

Impact of low mini-mental status on health outcome up to 5 years after stroke: the Erlangen Stroke Project. J Neurol (2011) 0.87

Trajectory of functional decline before and after ischemic stroke: the Northern Manhattan Study. Stroke (2012) 0.87

Consequences of stroke in community-dwelling elderly: the health and retirement study, 1998 to 2008. Stroke (2011) 0.85

Impact of post-stroke cognitive impairment with no dementia on health-related quality of life. J Stroke (2013) 0.85

Quality of life after lacunar stroke: the Secondary Prevention of Small Subcortical Strokes study. J Stroke Cerebrovasc Dis (2013) 0.78

Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study. J Aging Res (2011) 0.78

Ethnic Differences in Poststroke Quality of Life in the Brain Attack Surveillance in Corpus Christi (BASIC) Project. Stroke (2015) 0.75

Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke. Int J Mol Sci (2016) 0.75

Important considerations in lesion-symptom mapping: Illustrations from studies of word comprehension. Hum Brain Mapp (2017) 0.75

Life after Stroke in an Urban Minority Population: A Photovoice Project. Int J Environ Res Public Health (2017) 0.75

Relationship Between Language Preference and Intravenous Thrombolysis Among Acute Ischemic Stroke Patients. J Am Heart Assoc (2016) 0.75

Marfan Syndrome and Quality of Life in the GenTAC Registry. J Am Coll Cardiol (2017) 0.75

Articles cited by this

Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med (2003) 10.61

The behavioral risk factor surveys: II. Design, methods, and estimates from combined state data. Am J Prev Med (1988) 7.67

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis (1981) 7.00

Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol (1998) 5.54

The Mini-Mental State Examination. Arch Gen Psychiatry (1983) 5.20

The stroke impact scale version 2.0. Evaluation of reliability, validity, and sensitivity to change. Stroke (1999) 3.76

The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 3.12

Development of a stroke-specific quality of life scale. Stroke (1999) 2.87

Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke (2008) 2.84

Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke (1998) 2.70

The protective effect of moderate alcohol consumption on ischemic stroke. JAMA (1999) 2.68

Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke (2005) 2.51

Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study. Neurology (2007) 2.40

Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke (2009) 2.33

Long-term follow-up of survivors of acute lung injury: lack of effect of a ventilation strategy to prevent barotrauma. Crit Care Med (1999) 2.29

Long-term outcome after stroke: evaluating health-related quality of life using utility measurements. Stroke (2005) 2.29

Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology (2001) 2.18

Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA (2001) 2.16

Persisting consequences of stroke measured by the Stroke Impact Scale. Stroke (2002) 2.07

Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation (2009) 2.06

Testing the validity of the lacunar hypothesis: the Northern Manhattan Stroke Study experience. Neurology (1997) 1.80

Quality of life after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke (2004) 1.59

Quality of life after stroke. Impact of stroke type and lesion location. Stroke (1995) 1.59

Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology (2001) 1.43

Health status of individuals with mild stroke. Stroke (1997) 1.35

Current estimates from the National Health Interview Survey. United States, 1985. Vital Health Stat 10 (1986) 1.31

Clinical determinants of long-term quality of life after stroke. Age Ageing (2007) 1.27

Access to care among disabled adults on Medicaid. Health Care Financ Rev (2002) 1.20

Reliability of the activities of daily living scale and its use in telephone interview. Arch Phys Med Rehabil (1987) 1.17

Early cognitive impairment predicts long-term depressive symptoms and quality of life after stroke. J Neurol Sci (2006) 1.15

Socioeconomic variations in the course of stroke: unequal health outcomes, equal care? J Epidemiol Community Health (2002) 1.14

Evaluation of the Functional Assessment of Cancer Therapy-General (FACT-G) Spanish Version 4 in South America: classic psychometric and item response theory analyses. Health Qual Life Outcomes (2003) 1.11

A review and commentary of the social factors which influence stroke care: issues of inequality in qualitative literature. Health Soc Care Community (2003) 1.08

Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials. Qual Life Res (2008) 1.08

Long-term outcome in the North East Melbourne Stroke Incidence Study: predictors of quality of life at 5 years after stroke. Stroke (2005) 1.04

Separate and unequal care in New York City. J Health Care Law Policy (2006) 0.94

Cerebral leukoaraiosis in patients with stroke or TIA: clinical correlates and 1-year outcome. Eur J Neurol (2008) 0.90

Sickness impact after stroke. A 3-year follow-up. Scand J Prim Health Care (1992) 0.85

Quality of life measures in the Miami HIV-1 infected drug abusers cohort: relationship to gender and disease status. J Subst Abuse (2000) 0.85

Articles by these authors

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med (2001) 7.07

Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol (1998) 5.54

Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis (2006) 5.20

Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke (2001) 4.07

Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med (1992) 3.38

Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA (1999) 3.11

Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis (2012) 3.11

Mannheim intima-media thickness consensus. Cerebrovasc Dis (2004) 3.05

Projected costs of ischemic stroke in the United States. Neurology (2006) 2.93

American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke (1997) 2.87

High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA (2001) 2.85

Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke (1998) 2.70

The protective effect of moderate alcohol consumption on ischemic stroke. JAMA (1999) 2.68

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65

Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study. Neurology (2007) 2.40

Quality improvement in acute stroke: the New York State Stroke Center Designation Project. Neurology (2006) 2.40

Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology (2006) 2.36

The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology (2005) 2.32

AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: A statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. Stroke (1999) 2.32

Central poststroke pain and Wallenberg's lateral medullary infarction: frequency, character, and determinants in 63 patients. Neurology (1997) 2.28

Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology (1994) 2.21

Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA (2001) 2.16

Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology (2008) 2.09

Physical activity and risk of ischemic stroke in the Northern Manhattan Study. Neurology (2009) 2.02

Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke (1997) 2.00

Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-III. J Neurol Neurosurg Psychiatry (2009) 1.97

Coding neuroradiology reports for the Northern Manhattan Stroke Study: a comparison of natural language processing and manual review. Comput Biomed Res (2000) 1.93

Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (1999) 1.91

Social isolation and outcomes post stroke. Neurology (2005) 1.87

Testing the validity of the lacunar hypothesis: the Northern Manhattan Stroke Study experience. Neurology (1997) 1.80

Cerebrovascular reactivity and vasospasm after subarachnoid hemorrhage: a pilot study. Neurology (2006) 1.78

Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke (1999) 1.72

Survival and recurrence following stroke. The Framingham study. Stroke (1982) 1.69

Cost and outcome of mechanical ventilation for life-threatening stroke. Stroke (2000) 1.67

Role of vertebral artery hypoplasia in migraine. Cephalalgia (1998) 1.67

Elevated white blood cell count and carotid plaque thickness : the northern manhattan stroke study. Stroke (2001) 1.58

Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology (2004) 1.55

Metabolic syndrome and cerebral vasomotor reactivity. Eur J Neurol (2010) 1.53

Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke (1998) 1.52

Clinical discriminators of lobar and deep hemorrhages: the Stroke Data Bank. Neurology (1991) 1.50

The role of transcranial Doppler in confirming brain death: sensitivity, specificity, and suggestions for performance and interpretation. Neurology (1990) 1.49

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation (2001) 1.48

Laryngopharyngeal sensory testing with modified barium swallow as predictors of aspiration pneumonia after stroke. Laryngoscope (1997) 1.45

Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology (2001) 1.43

Supraglottic and pharyngeal sensory abnormalities in stroke patients with dysphagia. Ann Otol Rhinol Laryngol (1996) 1.42

Vascular distribution of paradoxical emboli by transcranial Doppler. Neurology (1993) 1.42

Impact of statins on the coagulation status of type 2 diabetes patients evaluated by a novel thrombin-generation assay. Cardiovasc Drugs Ther (2012) 1.39

Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke (1993) 1.39

Subarachnoid and intracerebral hemorrhage: natural history, prognosis, and precursive factors in the Framingham Study. Neurology (1984) 1.38

Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke (1994) 1.34

Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial. Stroke (2000) 1.34

Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology (2001) 1.31

Predictors of resource use after acute hospitalization: the Northern Manhattan Stroke Study. Neurology (2000) 1.31

Stroke recurrence within 2 years after ischemic infarction. Stroke (1991) 1.30

Validity of telephone interview data for vascular disease risk factors in a racially mixed urban community: the Northern Manhattan Stroke Study. Neuroepidemiology (1999) 1.29

Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology (1997) 1.27

Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology (2006) 1.27

Noninvasive detection of vertebral artery dissection. Stroke (1993) 1.27

Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study. Stroke (2000) 1.26

Carotid vascular abnormalities in primary hyperparathyroidism. J Clin Endocrinol Metab (2009) 1.26

The stroke prognosis instrument II (SPI-II) : A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. Stroke (2000) 1.24

Lower prevalence of silent brain infarcts in the physically active: the Northern Manhattan Study. Neurology (2011) 1.22

Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia (2005) 1.20